ArticleCancer medicine2023

Clinical efficacy and safety of adjuvant EGFR-TKIs for resected stage IB lung adenocarcinoma: A real-world study based on propensity score matching.

Leilei Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.